[The medical oncology clinic]

T Velu1, A Brandenburger, C Bruyns

  • 1tvelu@ulb.ac.be

Revue Medicale De Bruxelles
|February 15, 2003
PubMed

Insights

This research advances novel anticancer treatments by exploring gene therapy and immunotherapy. Key findings focus on oncogenes, cancer-immune interactions, and molecular diagnostics for improved cancer care.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology
  • Gene Therapy

Context:

  • The medical oncology clinic focuses on developing innovative anticancer therapies.
  • Pioneered gene therapy protocols in Belgium.
  • Research spans oncogenes, cancer immunology, and molecular diagnostics.

Purpose:

  • To advance the development of novel anticancer treatments.
  • To investigate the role of oncogenes in cell transformation.
  • To explore the interplay between cancer and the immune system.

Summary:

  • Focuses on molecular biology and immunology for new cancer treatments.
  • Highlights contributions to gene therapy, including novel vector development.
  • Investigates antitumor cell vaccines for advanced cell therapy.

Impact:

  • Contributes to the development of cutting-edge gene therapy techniques.
  • Advances understanding of cancer-immune interactions for therapeutic strategies.
  • Improves molecular diagnostic tools for personalized cancer medicine.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...